Breakthrough Therapy Designation further supports the differentiated clinical profile of CLN-081. Click link below to read press release. Source: https://investors.cullinanoncology.com/news-releases/news-release-details/fda-grants-breakthrough-therapy-designation-cullinan-oncologys
Year In Review – Recent Staffing Highlights
Market conditions continue to show subtle signs of improvement! New this week…
Gemini Staffing Announces New Hire
Attention Clinical Operations Directors: We have a unique opportunity with a Metro Boston-based biotech that is developing novel precision oncology programs. If you would like to learn about a company that offers what many can’t – a robust pipeline, an unrivaled veteran leadership team, a strong financial standing and a workplace that attracts and retains its people – we would love to hear from you. Please contact us today!
Featured Role – Director/Senior Director, Regulatory CMC – Remote, East Coast preferable